Clinical Trials Directory

Trials / Unknown

UnknownNCT02426177

Comparison of Tab.Labetalol and Tab.Nifedipine for Management of Postpartum Hypertension

Comparison of Oral Labetalol and Oral Nifedipine for Postpartum Hypertension Management

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
98 (estimated)
Sponsor
Dow University of Health Sciences · Academic / Other
Sex
Female
Age
20 Years – 48 Years
Healthy volunteers
Accepted

Summary

To compare effectiveness of oral labetalol and oral nifedipine for management of postpartum hypertension.

Detailed description

A comparison of oral labetalol and oral nifedipine for management of postpartum hypertension. Which drug is more effective in lowering blood pressures in patient with postpartum hypertension.

Conditions

Interventions

TypeNameDescription
DRUGLabetalolanti-hypertensive agents
DRUGNifedipinecalcium channel blocker ,for lowering blood pressure

Timeline

Start date
2015-05-01
Primary completion
2016-05-01
Completion
2016-12-01
First posted
2015-04-24
Last updated
2015-04-24

Source: ClinicalTrials.gov record NCT02426177. Inclusion in this directory is not an endorsement.

Comparison of Tab.Labetalol and Tab.Nifedipine for Management of Postpartum Hypertension (NCT02426177) · Clinical Trials Directory